Unaudited Interim Results for the six months ended 31 December 2025 -- 1 of 73 -- 2 Performance overview Normalised profit +24% to R8 891m Headline earnings +29% to R5 692m Normalised headline earnings +27% to R5 745m New business +12% to R14 026m -- 2 of 73 -- 3 Two prominent disruptive forces over the period Geopolitical rupture Proliferation of AI Source: World Economic Forum Global Risks Report 2026; McKinsey and Co The State of AI in 2025 -- 3 of 73 -- 4 Summary -- 4 of 73 -- 5 Key insights Evolving the Vitality Shared-value model to deliver hyper- personalised engagement and value through Vitality AI 1 2 3 Strong performance with continued delivery ahead of the five-year growth corridor targets Focused execution within each composite -- 5 of 73 -- 6 H1 FY26 performance to R8 891m +24% -- 6 of 73 -- 7 Strong operating profit growth Health 2 128 +5% Life 3 093 +15% Invest 984 +1% Insure 546 +34% Bank 75 <-100% Other SA1 -51 -80% Discovery SA 6 775 +19% VitalityHealth 1 186 +98% VitalityLife 352 +8% Ping An Health Insurance 573 +35% VHI - Other -16 -89% Vitality Network 176 -48% Vitality AI2 -155 >+100% Vitality 2 116 +41% Normalised profit, ZARm 1 Includes Discovery Vitality 2 Includes Other Vitality central costs 0 1 000 2 000 3 000 4 000 5 000 6 000 7 000 8 000 9 000 10 000 H1 2003 H1 2005 H1 2007 H1 2009 H1 2011 H1 2013 H1 2015 H1 2017 H1 2019 H1 2021 H1 2023 H1 2025 13% 15-yr CAGR 15% 5-yr CAGR to R8 891m +24% Normalised operating profit -- 7 of 73 -- 8 Solid new business Health 5 454 +16% 811 +26% Life 1 635 -1% | 16%* Invest 1 961 +13% | 19%* Insure 646 -2% Bank 1 438 +31% Vitality 246 -4% Discovery SA 9 942 +10% 2 249 29% VitalityHealth 1 440 +9% VitalityLife 1 495 +36% | 35%* Vitality Network 831 -14% Ping An Health Insurance 1 149 +6% VHI - Other 487 +5% Vitality 4 084 +16% 1 318 -8% ZARm New business Non-insurance income to R14 026m +12% New business 0 2 000 4 000 6 000 8 000 10 000 12 000 14 000 16 000 H1 2003 H1 2005 H1 2007 H1 2009 H1 2011 H1 2013 H1 2015 H1 2017 H1 2019 H1 2021 H1 2023 H1 2025 Sasolmed *New business APE -- 8 of 73 -- 9 Continued client growth SA Vitality excl. PAHI PAHI to 6.5m +7% to 11.2m +15% to 34.1m +17% 0 1 2 3 4 5 6 7 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 Millions 0 2 4 6 8 10 12 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 Millions 0 5 10 15 20 25 30 35 40 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 Millions Lives impacted -- 9 of 73 -- 10 Robust return on Group EV 17.3% Annualised return on EV Significant improvement in VNB Robust earnings from non-covered businesses Positive non-economic experience variances across all businesses Impact of economic assumption changes partially offset by forex movements R135 163m R126 554m R135 844m a b c d Econ variance and assumption changes Opening EV Non -econ variances & assumption changes Closing EV Operational EV Forex RDR unwind VNB Non -covered businesses Finance, investment returns & other Capital & dividend changes -- 10 of 73 -- 11 Robust cash generation 71% Cash conversion ratio Cash generated from in-force Cash uses: New business and tax Operating Cash Flow H1 2024 H1 2025 H1 2026 -R3.7bn New business net of external funding -R1.3bn Tax -R758m -R792m -R3.5bn -R3.5bn -R4.3bn -R4.3bn -R5.0bn H1 2024 H1 2025 H1 2026 Discovery Health Discovery Life Discovery Invest Vitality Health Insure Vitality Life R8.3bn R7.6bn R9.7bn H1 2024 H1 2025 H1 2026 R4.6bn R4.1bn R3.2bn Uncasted figures -- 11 of 73 -- 12 Group is well capitalised 1 Normalised for COVID-19 reserve impact, refer to Annexure A; 2 Capital Adequacy Ratio; 3 Comprehensive Solvency Ratio, definition set by China Banking and Insurance Regulatory Commission Strong cash conversion Strongly capitalised FLR decreasing Group cash conversion ratio1 Financial leverage ratio Solvency cover DHMS solvency (unaudited) Dec 25 Cover Dec 24 Cover Life 1.8x 1.8x Insure 2.1x 2.0x VH 1.7x 1.7x VL 1.9x 2.0x Bank2 1.1x 1.2x PAHI3 3.1x 3.4x 32.6% 10% 15% 20% 25% H1 FY23 FY23 H1 FY24 FY24 H1 FY25 FY25 H1 FY26 15.1% 10% 30% 50% 70% 90% H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 71% 31.0% -- 12 of 73 -- 13 Supportive below-the-line performance R million Actual Actual % H1 2026 H1 2025 Normalised profit from operations 8 891 7 188 24% Finance charges excl. 1DP finance lease -838 -954 Investment income and fair value gains on financial instruments 236 260 1 DP finance lease impact -25 -44 Other forex (losses)/gains -13 13 Other -63 -126 Profit before tax 8 188 6 337 29% Taxation -2 429 -1 845 Profit after tax 5 759 4 492 28% Profit not attributable to ordinary shareholders -90 -102 Loss on derecognition of intangible assets 21 16 Other headline earnings adjustments 2 22 Headline earnings 5 692 4 428 29% Amortisation of intangibles from business combinations 29 22 Restructuring costs - 36 Other normalised headline earnings adjustments 24 25 Normalised headline earnings 5 745 4 511 27% Interim ordinary dividend declaration of 111 cps 28% growth -- 13 of 73 -- 14 Delivery ahead of targets with confidence in achieving targets for FY26 and the remainder of the planning cycle Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors and reflects the average expected over the time frame *Spend on new includes Discovery Green, Vitality AI and VHI Other Performance Capital allocation Returns Cash conversion ratio (normalised history) Normalised profit growth % spend on new Dividend cover FLR Normalised RoE Expected FY26 H1 FY26 Targets 15-20% RoE 15-20% CAGR c5% Spend on new 10-20% FLR ≤5x Dividend cover 24% 15.1% 30-40% of expected full year dividend at H1 FY26 3%* Within plan Above plan Better than plan Within plan Within plan Within plan Scaled growth Investment Organic growth -20% 0% 20% 40% 0% 10% 20% 30% 0% 20% 40% 0% 50% 100% 0% 10% 20% 30% 0 5 60-70% Cash conversion ratio Illustrative ranges CAGR 9% CAGR 22% 8% 15%Average Average Average 56% 60% Average Average 22% 3%Average 4.6x 5.7xAverage Average Average 13%Average 20% FY 06 FY 15 FY 16 FY 24 FY 25 FY 29 H1 26 71% 17.4% -- 14 of 73 -- 15 3 Human-centric < AI-driven intelligence 4 Fragmented data < Quantified self • 90% of insurers are deploying or evaluating AI – yet only a small cohort is extracting material value. • AI is enabling 50–75% faster processing and ~20% cost savings in early adopters. • > 70% of global insurance purchases have traditionally been intermediary-led, yet up to 40% of broker activity can now be automated or augmented by AI. • ~ 97% of health data goes unused, with insight concentrated around illness rather than daily behaviour. • Digital health adoption accelerating as software, data & analytics become fastest-growing healthcare segments ~ 35% of adults in developed markets use wearables. • Sustained behaviour change proven (RAND study): 34– 40% activity uplift with Apple Watch and Vitality. 1 Actuarial dogma < Behavioural nature of risk 2 Generic approach < Predictive & personalised • Traditional insurance assumes risk is fixed at entry despite growing evidence that behaviour materially alters longevity. • Engagement remains minimal, with traditional insurers averaging ~40 customer interactions over 20 years. • Ageing populations, rising chronic disease and healthcare inflation are materially compressing affordability. • Standard treatment pathways are built for the “average patient”, with failure rates of up to 40% due to biological variation. • Predictive, personalised care improves adherence by ~42%, increases engagement >50%, & reduces readmissions by ~35%. • GLP-1 therapies now account for ~10% of employer claims, but behaviour-linked pathways can reduce long-term cost trend. Structural forces reshaping insurance industry – amplifying advantage for models built on data and behaviour change Sources: Swiss Re Institute (2025), Sigma No. 5/2025: Global economic and insurance outlook – Shifting sands; McKinsey & Company (2025), What to expect in US healthcare; Swiss Re Sigma (2025), historical data on real healthcare cost growth vs GDP; Mandalore Partners (2025), Major Insurtech Trends: AI, Personalization & Automation; McKinsey Global Insurance AI Commentary (2024–2025); NBOA (2025), GLP-1 drugs now ~10% of employer annual claims; Deloitte (2024–2025), Digital Consumer Trends AI is reshaping the industry’s economics and widening the gap between intelligent, AI-native insurers extracting operating leverage at scale and legacy players preserving traditional models. Health is shifting from episodic measurement to continuous self-management, making personal agency central to value perception and product design in health and insurance. Passive, one-off risk pricing models are structurally exposed to rising claims & margin erosion, accelerating the shift to dynamic, behaviour-driven models. Healthcare is shifting from treating populations to managing individual risk, increasing the need for personalised behavioural intervention. -- 15 of 73 -- 16 Broad-based contribution in Discovery SA, with a strong contribution from VitalityHealth in the Vitality composite Discovery SA profit growth build-up Vitality profit growth build-up 39% 2% 9% 10% -11% -8% 41% VitalityHealth VitalityLife VHI - Other PAHI Vitality Network Vitality AI Vitality 2% 7% 2% 4% 4% 0.2% 19% Discovery Health Discovery Life Discovery Invest Discovery Insure Discovery Bank Other Discovery SA -- 16 of 73 -- 17 The architecture of the Vitality Shared-value model -- 17 of 73 -- 18 Shared value results in a structurally different value chain that generates significant alpha 𝛼 OPTIMISED RETENTION SHARED-VALUE INCENTIVES + + -BEHAVIOUR CHANGE DYNAMIC PRICING x VOLUME 𝑒𝑥 𝑷𝒓𝒆𝒎𝒊𝒖𝒎 𝑼𝒏𝒊𝒕 𝒐𝒇 𝑹𝒊𝒔𝒌 ∆ 𝑩𝒆𝒉𝒂𝒗𝒊𝒐𝒖𝒓 𝑼𝒏𝒊𝒕 𝒐𝒇 𝑹𝒊𝒔𝒌 × ∆ 𝑪𝒍𝒂𝒊𝒎𝒔 ∆ 𝑩𝒆𝒉𝒂𝒗𝒊𝒐𝒖𝒓 ∆ 𝑯𝒆𝒂𝒍𝒕𝒉𝒚 𝑳𝒊𝒗𝒆𝒔 ∆ 𝑻𝒐𝒕𝒂𝒍 𝑳𝒊𝒗𝒆𝒔 ∆ 𝑰𝒏𝒄𝒆𝒏𝒕𝒊𝒗𝒆 ∆ 𝑩𝒆𝒉𝒂𝒗𝒊𝒐𝒖𝒓 -- 18 of 73 -- 19 VitalityLife is a leading UK life insurer driving superior shared-value performance 47% lower lapses with 75% more healthy lives after 20 years Optimiser policies experience 18% lower claims 24-53% more premium per unit of risk >5x price elasticity results in large volume from small prices changes Average consumer value uplift over first 3 years is 30-59% of premiums 𝑷𝒓𝒆𝒎𝒊𝒖𝒎 𝑼𝒏𝒊𝒕 𝒐𝒇 𝑹𝒊𝒔𝒌 ∆ 𝑩𝒆𝒉𝒂𝒗𝒊𝒐𝒖𝒓 𝑼𝒏𝒊𝒕 𝒐𝒇 𝑹𝒊𝒔𝒌 × ∆ 𝑪𝒍𝒂𝒊𝒎𝒔 ∆ 𝑩𝒆𝒉𝒂𝒗𝒊𝒐𝒖𝒓 ∆ 𝑯𝒆𝒂𝒍𝒕𝒉𝒚 𝑳𝒊𝒗𝒆𝒔 ∆ 𝑻𝒐𝒕𝒂𝒍 𝑳𝒊𝒗𝒆𝒔 ∆ 𝑰𝒏𝒄𝒆𝒏𝒕𝒊𝒗𝒆 ∆ 𝑩𝒆𝒉𝒂𝒗𝒊𝒐𝒖𝒓 +39% +68% +17% -49% +35% New business value impact 𝛼 New business value improvement +110% ~ RF+9% New business value margin 𝑒𝑥 added to customers’ lives +5 years OPTIMISED RETENTION SHARED-VALUE INCENTIVES + + -BEHAVIOUR CHANGE DYNAMIC PRICING x VOLUME Analysis results shown are derived from a portfolio-level analysis based on a defined cohort of shared-value business observed over a specified multi-year period -- 19 of 73 -- 20 Shared value delivering demonstrable alpha across the businesses over the period Cost per benefit unit1 -17.7% LONG-TERM BUSINESSES SHORT-TERM BUSINESSES 11.3% Operating margin 15.2% Operating margin 1% Operating margin RF+9% New business IRR RF+8% New business IRR 1 Contribution differential between Discovery Health Medical Scheme and the next seven competitors; 2 Gold and Diamond Vitality status members relative to non-engaged (Blue Vitality status) MEDICAL SCHEME OPTIMISED RETENTION SHARED-VALUE INCENTIVES + + -BEHAVIOUR CHANGE DYNAMIC PRICING x VOLUME 𝛼 𝑒𝑥 added to customers’ lives +5 years added to engaged customers’ lives2 +6 years Longer investment terms +3.4 years Lower claims on average for Vitality members -20% Lower road fatality rates for engaged members2 -74% Lower hospital admissions for engaged members2 -16% -- 20 of 73 -- 21 OPTIMISED RETENTION SHARED-VALUE INCENTIVES + + -BEHAVIOUR CHANGE DYNAMIC PRICING x VOLUME Shared value delivering demonstrable alpha across the businesses over the period 𝛼 +82% VNB improvement +110% New business value improvement +48% Profit margin increase +124% Margin increase Analysis results shown are derived from a portfolio-level analysis based on a defined cohort of shared-value business observed over a specified multi-year period -- 21 of 73 -- 22 +19% +41% H1 FY26 profit growth: -- 22 of 73 -- 23 Focused execution of the Vitality Shared-value model within each composite Proprietary data Dynamic risk assessment Vitality.AI recommender Incentivised engagement Insurance integration -- 23 of 73 -- 24 Discovery SA Discovery Bank Discovery Insure Discovery Invest Discovery Life Discovery Health -- 24 of 73 -- 25 Green shoots emerging in the South African context 2023/4 Position 2025/Current Energy 98% reduction in loadshedding 290 days of loadshedding 7 days of loadshedding (2025) Transport and logistics 22Mt increase in annual freight railed 34% drop in rail volumes1 +15% increase in rail volumes Crime and corruption Removal from the FATF list FATF Grey list Deficient in 20/40 areas SA removed from FATF grey list Economic growth Moderate but improving GDP growth 2024: 0.5% 2025F: 1.2-1.6% | 2026P: 1.4-1.9% Government bond yields (10-year) Bond yields benefited from improved sentiment Jan 2025: 10.38% YTD: 8.10% Inflation Inflation at a 21-year low 2024: 4.4% 2025: 3.2% Exchange rate Currency stability with the Rand appreciating End 2024: R18.71/$ YTD: R16.13/$ S&P credit rating First major rating upgrade in over 16 years Foreign currency: BB- Local: BB Foreign currency: BB Local: BB+ (positive outlook) 1 226Mt in FY17/18, vs R149Mt FY22/23 Sources: South African Reserve Bank; Investing.com; StatsSA, National Treasury, International Monetary Fund -- 25 of 73 -- 26 Disciplined execution and delivery against targets Discovery Bank Discovery Insure Discovery Invest Discovery Life Discovery Health Leading financial services group in SA which, through its fully Bank-integrated composite and Vitality Shared-value model, creates a unique shared-value customer- centric composite Measure KPI target H1 FY26 Bank Operating profit growth p.a. R400m R220m FY29 profit ambition R3bn On track Life Life and Invest new business IRR >RF+8% RF+8% (16.8%) Insure Margin c10% 15.2% Discovery SA Earnings growth CAGR (FY25-FY29) 12.5% - 17.5% p.a. 19% -- 26 of 73 -- 27 A full-service digital shared-value retail Bank Key hypotheses 1 Using organic balance sheet growth. The analysis considers year-on-year growth in retail deposits: adjusting for the impact of any mergers or acquisitions, retail advances: credit cards (excl. overdrafts) and home loans. It does not consider other factors such as profitability, customer experience and operational scale. Based on Dec 2025 BA900s Fastest growing1 retail Bank in South Africa with market-leading digital capabilities Shared-value banking model1 | Full retail banking product suite2 | Digital-first with advanced AI capabilities3 | #1 Bank brand # 1 Retail and private banking service Jul-21 Jan-26 -- 27 of 73 -- 28 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 Accounts Clients Discovery Bank Deposits Revenue (NII+NIR) Profit +28% +21% +>100% +34% to 1.4m to R25.7bn to R75m to R1.5bn Gross retail Advances +42% to R11.1bn Total accounts Total clients +29% to 3.4m NII includes the allocation of interest earned on Treasury Bills (recognised at fair value gains in the income statement) H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 NII NIR H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 -- 28 of 73 -- 29 Sales growth scaling efficiently 1 New business from clients who do not have any qualifying Discovery products (Discovery Health, Invest, Insure, Vitality, Gap and Life) Daily sales Acquisition costs Sales mix 0 200 400 600 800 1 000 1 200 1 400 1 600 Jul-21 Oct-21 Jan-22 Apr-22 Jul-22 Oct-22 Jan-23 Apr-23 Jul-23 Oct-23 Jan-24 Apr-24 Jul-24 Oct-24 Jan-25 Apr-25 Jul-25 Oct-25 Jan-26 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% H1 2024 H1 2025 H1 2026 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Jan-24 Apr-24 Jul-24 Oct-24 Jan-25 Apr-25 Jul-25 Oct-25 New to Discovery Existing Discovery client Average sales per workday (calendar month) Acquisition costs pcpm baselined to H1 2024 New business by number of existing Discovery products Product mix New business by product mix 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% H1 2022 H2 2022 H1 2023 H2 2023 H1 2024 H2 2024 H1 2025 H2 2025 H1 2026 TRX Bundled, Credit and Suite Savings and TRX PAYT 1 -- 29 of 73 -- 30 Balance sheet growth with improving credit quality HL: Homeloans, PL: Personal loans; RCF: Revolving Credit Facility Deposits Gross retail advances Impairments per client 0 5 000 10 000 15 000 20 000 25 000 30 000 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 -5 5 15 25 35 45 55 65 75 85 H1 2022 H2 2022 H1 2023 H2 2023 H1 2024 H2 2024 H1 2025 H2 2025 H1 2026 Average NII pcpm Average Impairments pcpm 0 2 000 4 000 6 000 8 000 10 000 12 000 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 HL PL & RCF CC & DTA overdraft 11 051 Impairment pcpm vs NII pcpm (R) (Rm) (Rm) -- 30 of 73 -- 31 Increasing engagement levels driving NIR growth Spend1 NIR per client NIR per client by duration2 1 Restricted on active clients; 2 Standardising for current new business mix (0-3 months) sold in H1 2026 and baselined to duration 0-3 months Engagement 576k Flights booked 5.56bn Miles earned 7.8m Baskets earning HealthyFood rewards During H1 FY26 Spend pcpm baselined to H1 2022 Baselined NIR pcpm 0 20 40 60 80 100 120 140 160 3 6 12 24-60 >60 Months on Bank NIR pcpm before NBAC 0 20 40 60 80 100 120 140 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 0% 20% 40% 60% 80% 100% 120% H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 -- 31 of 73 -- 32 Scalability gains driving operational margin expansion Profitability = Client growth x Revenue pc Expenses pc Impairments pc - - { } At 2-2.5m clients, operating profit → R3bn and 𝜶 = 𝑪𝒐𝒔𝒕 𝑰𝒏𝒄𝒐𝒎𝒆 → 40-50% 336 255 204 166 144 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 Expenses pcpm (R) (excl. NBAC) ( 408.0) ( 266.7) ( 154.0) 69.2 318.9 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 Profit Before NBAC (Rm) 64 80 79 78 77 89 101 109 115 122 0 20 40 60 80 100 120 140 160 180 200 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 Revenue pcpm (R) (excl. NBAC) NII pcpm NIR pcpm 19 14 18 16 16 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 Impairments pcpm (R) 0.39 0.58 0.83 1.09 1.40 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 Clients (millions) -- 32 of 73 -- 33 Discovery Bank as the composite-maker Key hypotheses 1 Using organic balance sheet growth. The analysis considers year-on-year growth in retail deposits: adjusting for the impact of any mergers or acquisitions, retail advances: credit cards (excl overdrafts) and home loans. It does not consider other factors such as profitability, customer experience and operational scale. Based on Dec 2025 BA900s Fastest growing1 retail Bank in South Africa with market-leading digital capabilities Shared-value banking model1 | Full retail banking product suite2 | Digital-first with advanced AI capabilities3 | Operating system of the composite4 | -- 33 of 73 -- 34 Discovery Bank as the composite-maker Enablers Value drivers Consistent business model and architecture Data and AI Unique Bank capabilities *Assumes 30% of Bank app leads would have been received organically via other channels had Bank app enhancements not been done Acquisition and origination* Security Functionality Service Shared value and rewards In-app calling Clients falling victim to EFT fraud (Indexed to Oct-25) 100% 85% 87% 48% 20% Oct-25 Nov-25 Dec-25 Jan-26 Feb-26 Health leads from Bank 77% Uplift vs baseline Life leads from Bank Insure leads from Bank 127% Uplift vs baseline 98% Uplift vs baseline In-App Calling Discovery 911 1 2 3 Payments Security Ecosystems ~9.5m daily data events -- 34 of 73 -- 35 Discovery Health Figures are excluding Healthy Company in prior periods Normalised profit New business Non-scheme growth Membership +5% +16% 3.86m to R2 128m to R5 454m Lives under administration >305k lives 20% H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 1993 1996 1999 2002 2005 2008 2011 2014 2017 2020 2023 2025 Non Scheme Products Restricted Schemes DHMS Jan-18 Aug-18 Mar-19 Oct-19 May-20 Dec-20 Jul-21 Feb-22 Sep-22 Apr-23 Nov-23 Jun-24 Jan-25 Aug-25 Flexicare Gap cover AHI Includes R125m ATB concession -- 35 of 73 -- 36 Actively addressing the issues of ageing and chronicity in the Scheme PHP: Personal Health Pathways; PHP engagement statistics as at 28 February 2026 Positive selection from Active Smart AI-driven behaviour change through PHP January 2025 December 2025 Number of lives 4x Fastest growing plan in the market Active Smart Chronic ratio 60% lower than rest of DHMS Average age 6.4 years younger than rest of DHMS 1.39x 1.40x 1.55x 1.79x 1.86x 2.10x 2.10x Prostate screening Blood glucose test Cervical cancer screening Colon cancer screening Mammogram Flu vaccine Foot screening Completion rate relative to non-PHP members 575k Activated lives 5.2m Exercise actions completed 67% Of all actions are completed by chronic lives 887k Health actions completed -- 36 of 73 -- 37 Sustained growth and financial strength for DHMS Customer satisfaction and stability Lower weighted contribution increase Market share Solvency 0% 1% 2% 3% 2021-22 2023-24 2025-26 Upgrades Downgrades 96% 5.5% Members with no plan changes Lapse rate 0% 5% 10% 15% 20% 25% 30% 35% 40% 0 5 10 15 20 25 30 35 2021-22 2023-24 2025-26 Reserve Actual Solvency Required Solvency R33.1 bn 32.6% AAA Projected unaudited reserves Projected unaudited solvency Credit rating DHMS Rest of the industry Others 57.7% Market share 1 Effective contribution differential between DHMS and the next seven competitors; Effective contribution differential and increases take into account contribution deferrals 9.6% 9.3% 5.4% 10.8% 11.1% 10.1% 2024 2025 2026 DHMS Next top 7 competitors 17.7% lower cost per unit benefit 1 -- 37 of 73 -- 38 National Health Insurance (NHI) Act developments Discovery’s position: NHI is not workable without private sector collaboration NHI developments Scheduled hearings on 5-7 May 2026 on the constitutionality of Parliament’s public participation process prior to the assent to the NHI Act 1. ConCourt process ongoing Proclamation and/or implementation of any sections of the NHI Act paused until the ConCourt delivers ruling 2. High Court order of 24 February 2026 Inflationary increase (3.3%) in medical scheme tax credits in the 2026/27 budget with no structural changes In the event of future amendments to tax credits, these would likely only affect tax-payers earning more than R1m p.a. 3. Medical Scheme Tax Credits -- 38 of 73 -- 39 Discovery Life Normalised profit Cash generation New business +15% to R3 093m Individual Life -1% to R1 635m IFRS 17 Individual Life Corporate & Employee Benefits (CEB) +9% Discovery Life Ltd Cash flow before financing initiatives and dividends to Group (Rbn)+6% New business APE (EV) +16% H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 +16% Leading market share - 2.4x the average of the next 5 largest writers in the underwritten retail risk business1 1. Market share source: NMG market report Q4 2025 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 1.5 1.6 0.6 1.1 0.8 New business API -- 39 of 73 -- 40 June 2025 New Business Expected Unwind excl. new business Experience Variances Economic Dividends Other December 2025 301 2 287 978 4 046 - 800 - 9 52 164 58 967 June 2025 ortality and morbidity ium and fee income Persistency Policy alterations Other Total non-economic Economic Total Positive operating variances, robust EV growth and improved VNB margin Positive operating variances Improved VNB margin Growth in Embedded Value Individual Life: 3.8% (IRR: RF +6.8%) Life (excl. Invest) VNB margin (%) Individual Life: 5.5% (IRR: RF + 8%) 31.3% Annualised RoEV2 14.1% excl. economic updates Discovery Life Ltd EV variances (Rm) Discovery Life Ltd EV growth (Rm) 389 1 080 1 Defined action plan being phased in to address policy alterations. Material componentsof it implemented with positive outcomes starting to be observed. June 2025 Economic Business mix Model changes Other December 2025 2.1% 4.3% June 2025 December 2025 Premium & fee income Persistency Other Total non -economic Economic Total Policy alterations 1 Mortality & morbidity December 2025 1 Defined action plan being phased in to address policy alterations. Material components of it implemented with positive outcomes starting to be observed; 2 Before dividend payments. Economic assumptions 1 080 -111 58 968 -- 40 of 73 -- 41 Tension between policy alterations and claims variances are being actively managed Positive operating variances (Rm) Claims gain offsetting the policy alterations strain Mortality and morbidity Premium and fee income Persistency Policy alterations Other Total non-economic Economic Total 389 1 080 Persistency Premium & fee income Other Total non -economic Economic Total Policy alterations Mortality & morbidity Shared-value model drives continued risk improvements Policy alterations variances have remained a key priority Increased Vitality health engagement in the Discovery Life book (API distribution) Further improved experience observed for engaged policyholders (Mortality experience relative to expected) Actions are being phased in – some lead time until negative variance fully closed Improvement observed in underlying lapses, offsetting stress lapse assumption run-off Blue Bronze Silver Gold Diamond +15% 100% None / Blue Bronze / Silver Gold / Diamond -20% -35% H1 2023 H1 2026 H1 2023 H1 2026 H1 2023 H1 2026 H1 2023 H1 2026 H1 2023 H1 2026 +10% H1 2025 H1 2026 H1 2025 H1 2026 H1 2025 H1 2026 Dec-25 observed policy alterations and lapses Impact of actions now live1 Interventions under development1 Indicative policy alterations and lapses net of interventions 0 1 Estimated based on historic experience Long-term claims experience observed at 93% -- 41 of 73 -- 42 Value generation of business under IFRS 17 CSM, RA and IFR increased over the period ZARm 23 251 34 084 7 395 3 053 1 046 - 382 -1 359 Store of value June 2025: CSM + RA + OCI New Business Insurance finance income/ expense Non-financial risk variances and basis changes Release to earnings Store of value December 2025: CSM + RA + OCI = c47% Growth from June 2025 OCI RA 11 529 Includes lapses, policy alterations, basis updates CSM 1 081 1 166 1 430 497 3 093 CSM & RA release IFIE Other Life segment earnings Components of Life segment earnings (incl. Premium Allocation Approach (PAA) business such as Group Life) Includes claims and NAV variances CSM = 23 507 RA = 7 877 IFR = -8 133 CSM = 24 103 RA = 10 509 IFR = -528 CSM = Contractual Service Margin; RA = Risk Adjustment; IFR = Insurance Finance Reserve; OCI = Other Comprehensive Income; IFIE = Insurance Finance Income or Expense Store of value is calculated net of reinsurance but gross of tax net of IFR net of IFR , , -- 42 of 73 -- 43 Jul-21 Jan-22 Jul-22 Jan-23 Jul-23 Jan-24 Jul-24 Jan-25 Jul-25 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 Discovery Invest Normalised profit New business Assets under administration +1% +13% +20% to R984m to R1 961m to R200bn +21% Accounting for once- off impacts Once-off gains Once-off losses +1% -- 43 of 73 -- 44 Discovery Insure Normalised profit Insurance revenue Operating margin Gross new business +34% +4% +24% -2% to R546m to R3 207m to R646m H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 to 15.2% H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 -- 44 of 73 -- 45 Vitality model compounds duration-driven outperformance 1 New Business based on policies with duration of less than 12 months during the period Client quality improves by duration Lower accident frequency by status and duration Lapses improve by both status and duration 0% 20% 40% 60% 80% 100% Duration 1 Duration 2 Duration 3 Duration 4 Duration 5 Blue Bronze Silver Gold 0% 20% 40% 60% 80% 100% Blue Bronze Silver Gold Diamond Duration 1 Duration 5 Status distribution by duration Relative accident frequency by status and duration Relative lapse rate by status and duration 0% 20% 40% 60% 80% 100% Blue Bronze Silver Gold Diamond Duration 1 Duration 5 -71% 0% 20% 40% 60% 80% 100% H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 Loss ratio of new business continues to improve New business1 loss ratio (rebased) -28% -- 45 of 73 -- 46 Management initiatives and Vitality model drive loss ratio improvements Loss ratio shows sustained improvement Full book loss ratio Full book weather loss ratio Full book non-weather loss ratio 10% 20% 30% 40% 50% 60% 70% H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 0% 5% 10% 15% 20% H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 0% 10% 20% 30% 40% 50% 60% 70% H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 -29% -- 46 of 73 -- 47 Vitality Vitality Health International Vitality Network Vitality UK -- 47 of 73 -- 48 Unique macro contexts in key markets United States • Resilient GDP growth and inflation moderating with Treasury yields easing in Q3, with 10-year yields drifting toward ~4% amid improved growth • Wellness economy booming: $2.31tn (2025) → $3.70tn by 2034 (5.4% CAGR) • Market volatility driven by regulatory unpredictability around vaccination policies, ACIP overhaul, and FDA resignations (Moderna fell 11%, Novavax 6%, BioNTech 7%, and Pfizer 2%) • In the second quarter of 2025, relative to the S&P 500, the US healthcare sector produced its worst quarterly return in recent history (>20% decline in US healthcare valuations vs rest of S&P 500) United Kingdom • Stabilising but subdued growth • Gilt yields reached their highest levels in 25 years due to fiscal concerns and sticky inflation • Increases in National Insurance contributions (from 13.8% to 15%) increasing labour costs and putting pressure on SMEs • NHS facing widening financial pressures, with a £2 billion deficit and substantial backlogs (~7.29 million) China • GDP growth slowing to 4.8% in Q3 2025, with broad slowdown across industrial production and services • Persistent deflationary pressure due to weak consumer demand and excess capacity • Stimulus measures ongoing but confidence remains fragile • Late-October rally in the Shanghai Composite saw the index trading above 3 900 (up ~28% since April) • Government supportive of health insurance growth and long-term care expansion; 15th Five-Year Plan to widen coverage and gradually raise retirement age (2025–2030) 0% 2% 4% 6% 8% 10% 2021 2022 2023 2024 2025E 2026F GDP growth 0% 2% 4% 6% 8% 10% 2021 2022 2023 2024 2025E 2026F 0% 2% 4% 6% 8% 10% 2021 2022 2023 2024 2025E 2026F -- 48 of 73 -- 49 Disciplined execution and delivery against targets Transforming global insurance through shared value powered by Vitality AI Vitality Health International Vitality Network Vitality UK Measure KPI target H1 FY26 Vitality UK Premium growth (GBP) >10% 14% Life new business IRR >RF+5% RF+9% (13%) Health gross margin c7.5% 11% Vitality Network Revenue growth (USD) c15% -12% Operating margin c50% 21% Vitality Health International PAHI premium growth above market >5% 9% PAHI Preserving quality profit growth Achieved VitalityHealth US break-even FY27 On track Vitality Earnings growth CAGR (FY25-FY29) 20% - 30% p.a. 41% -- 49 of 73 -- 50 Vitality strategic focus areas 2 Develop Vitality UK into a best-in-class health and life insurer, and a centre of excellence for global expansionVitality UK Continue to scale while adjusting to the change in Ping An Life distribution 5 Ping An Health Insurance 3 Restructure existing partnerships for maximum impact and growth, and rapidly pursue new partnerships in Europe Vitality Network 4 Scale VitalityHealth US and Amplify Health in Asia, and ensure they are profitable Vitality Health International 1 Develop and launch Vitality AI with Google into a single unique capabilityVitality AI -- 50 of 73 -- 51 Vitality AI | Google – A defining global launch -- 51 of 73 -- 52 Vitality AI | Google – Amassed a rich and comprehensive dataset that allows us to extract unique insights Consolidated on a single platform containing over 60 million life years (2 800 dimensions) of behavioural- linked insurance data spanning 30 years Incentives Demography Operational Device data Clinical -- 52 of 73 -- 53 Vitality AI | Google – Harnessing data and AI to unlock behavioural precision and engagement at scale Combining Google’s secure, scalable cloud and AI capabilities with Vitality’s unique data assets, AI and actuarial models, and leadership in incentivised behaviour change and shared value to deliver precise and personalised health improvement actions at scale -- 53 of 73 -- 54 Vitality AI | Google – Offering the right incentive, at the right moment, in a personalised manner Global Partner Network An integrated incentive and personalised communication framework to reinforce engagement loops and sustain long- term behaviour change Personalised communication Personalised using LLMs, generative AI, entity profiles and indices to optimise content and infrastructure -- 54 of 73 -- 55 Vitality AI | Google – Impact on behaviour and risk has been recognised by leading reinsurers Global Shared-Value Reinsurance Panel A library of dynamic pricing models and heuristics, with price optimisation across all relevant areas, underpinned by an exclusive reinsurance panel Personalised mortality curves and dynamic pricing models Healthy Gear Inclusion of Vitality rating factor within reinsurance agreements Upfront selection discounts in reinsurance rates, recognising the positive selection associated with Vitality-engaged clients Additional behaviour change discounts automatically released to insurers if the distribution of policyholders’ physical activity levels improve Deep understanding of how mortality changes based on behaviour Age Mortality Premium Policy term Dynamic pricing of controllable risk through policy term -- 55 of 73 -- 56 Vitality AI | Google – Manifesting in a seamless and intuitive customer experience Core lifestyle behaviours Physical activity Sleep Priority actions High-risk management -- 56 of 73 -- 57 Vitality UK Normalised operating profit of VitalityHealth and VitalityLife Normalised profit Premium income Lives covered New business +65% +14% +7% +20% to £66.0m to £698.5m to 2.02m to £126.0m H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 GBP millions H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 GBP millions IFRS 17 -- 57 of 73 -- 58 VitalityHealth Normalised profit Insurance revenue Lives covered New business API +97% +14% +2% +8% to £50.9m to £450.8m to 1.06m to £61.8m H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 GBP millions GBP millions GBP millions IFRS 17 -- 58 of 73 -- 59 Operating margin H1 H2 H1 H2 H1 H2 H1 H2 H1 H2 H1 H2* FY21 FY22 FY23 FY24 FY25 FY26* Half-year margin Full-year margin 7.5% margin Higher margins in H1 driven by normal claims seasonality *Forecast Margin recovery enabled by shared value dynamics and stabilising claims environment Premiums vs claims PLPM (indexed to 2023) Premiums rebased to match increased claims Continued recovery of margins 95% 100% 105% 110% 115% 120% 125% 130% Dec-22 Mar-23 Jun-23 Sep-23 Dec-23 Mar-24 Jun-24 Sep-24 Dec-24 Mar-25 Jun-25 Sep-25 Dec-25 Premiums Claims (rolling 6m) Selective retention of healthier lives Policy lapse rate and claims relativity by status (indexed to overall rate) 0% 20% 40% 60% 80% 100% 120% Bronze Silver Gold Platinum Individual lapse rate SME lapse rate Overall rate Claims relativity by Vitality status1 (after normalising for other claims factors) Impact of increased engagement on claims 7.5% 1.00 0.84 0.81 0.72 Bronze Silver Gold Platinum 1. GLMs were used to adjust for key risk factors (e.g. age, location, product mix, duration, underwriting type, sales channel), isolating the relative impact of individual factors by holding others constant FY26 FY26 margin is expected to be above 7.5% -- 59 of 73 -- 60 VitalityLife Normalised profit Premium income Lives covered New business +7% +14% +12% +35% to £15.1m to £247.7m to 958k lives to £64.2m H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 IFRS 17 GBP millions GBP millions GBP millions -- 60 of 73 -- 61 Significant new business value and margin growth enabled by Shared-value Insurance Model VLUK new business market share1 Significant increase in new business traction Optimiser drives improvement in mortality Sales growth + efficiencies driving value Mortality by status (Jul 22 - Dec 25, plans with Optimiser, indexed to Bronze) Lapse rate by status (12m to Dec 25, indexed to Bronze) Increased engagement leads to greater retention New business net value (£m) (CSM & RA, less onerous new business) -0.2 24.3 34.6 Bronze Silver Gold Platinum Bronze Silver Gold Platinum 47% 47% 1. Gen Re Protection Pulse 7.4% 10.1% 10.5% 12.4% 14.8% Up to 50% in 24 months Advisers writing: 44% more additional covers selected 10% greater average benefit size Mix improvements with Optimiser: H1 2024 H1 2025 H1 2026 H1 2024 H1 2025 H1 2026 H1 2023 H1 2022 -- 61 of 73 -- 62 Value generation of business under IFRS 17 CSM, RA and IFR increased over the period GBPm CSM = Contractual Service Margin; RA = Risk Adjustment; IFR = Insurance Finance Reserve; OCI = Other Comprehensive Income; IFIE = Insurance Finance Income or Expense Store of value is calculated net of reinsurance but gross of tax The new business margins generated of £37.3m excludes the impact of new reinsurance contracts attaching to the in-force book in the period. The total CSM and RA on new contracts incepted in the period was £29.5m. The difference is included in "Non-financial risk, variance, basis changes and other" 552.2 600.8 4.2 6.9 Store of value June 2025: CSM + RA + OCI New business Insurance finance income/expense2 Non-financial risk variances, basis changes and other Release to earnings Store of value December 2025: CSM + RA + OCI = 9% Growth from June 2025 OCI CSM+RA -20.3 11.1 20.5 37.3 , RA, net of IFR net of IFR -- 62 of 73 -- 63 Vitality Network Integrated API by insurance partners Revenue Insurance partners membership Normalised profit +13% to $1 026m -12% to $48m -46% to $10.2m +11% to 6.9m USD millions USD millions USD millions Macroeconomic gains Macroeconomic losses +2% accounting for macro impacts H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 +7% accounting for macro impacts H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 -- 63 of 73 -- 64 The model has been successful for our partners Integrated insurance premium1 Integrated API Integrated API H1 2023 H1 2024 H1 2025 H1 2026 H1 2023 H1 2024 H1 2025 H1 2026 H1 2023 H1 2024 H1 2025 H1 2026 +23% +10% +14% 1 Integrated Insurance Premium represents the cumulative in-force members annualised net premium -- 64 of 73 -- 65 • Unveiled to key stakeholders in London in November 2025 • Included announcement of strategic partnership with Google, introduction of panel of shared-Value reinsurance partners, and several new Vitality Programme partners Launched Vitality AI 1 • An amicable end to the Generali partnership has opened up the European insurance market. On the back of the success of shared-value insurance and the Vitality AI launch, we are actively building a new carrier network across Europe Growing opportunities in Europe 4 • Rebased SLI revenue assessment, making the revenue stream more consistent and predictable • Collectively committed to driving growth in SLI, to reach goal of 5m lives by 2030 Capitalising on emergence of value in SLI 2 • Accelerating shared-value insurance and Vitality AI product rollout in key AIA markets via investment alongside AIA Investing in AIA Vitality partnership 3 • The largest life insurance market in the world remains a strategic opportunity for growth together with John Hancock and other non-competing carriers Driving growth in North America 5 Considerable progress in positioning the business for scale and growth -- 65 of 73 -- 66 Enhanced SLI commercial terms have created a large, Yen-denominated asset for the Group Yen and interest rate movements Asset value at Dec-25 USDm Fixed revenue recognition1 -9% change in JPY/USD from Jun-25 to Dec-25 63bpsincrease in Japanese risk-free rate from Jun-25 to Dec-25 1 Under the revised terms, VGI earns a fixed proportion of Gross Written Premium . The indicative fixed revenue recognition represents the expected value of this fixed proportion should new business, FX and risk-free rate assumptions hold SLI = Sumitomo Life Insurance $62m Before macro impacts Accounting value -9% Calculated using a discount rate of risk- free + 10% 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 Recognition of new tranches Unwind of tranches -- 66 of 73 -- 67 Vitality Health International Note: Quantium Health, which is part of VHI, has not been included in this update ; WSH = WellSpark 1 Successful acquisition of WellSpark, including valuable contract with EmblemHealth, with the migration of >1m members onto the Vitality AI platform 2 Strong momentum in US health-plan sales – a key strategic segment – adding 2.5m members from 1 January 2026 3 Rollout of Vitality AI, coaching and clinical programmes across all the new health plan and employer clients from 1 January 2026 Ongoing rollout of scalable, AI-enabled and data-driven solutions across Asia-Pacific, including an integrated product package with multi-year value-share economics in four key markets 1 Three prestigious awards received for advancing health technology services in Asia Pacific 2 Excellent performance, driven by robust operating margins together with a substantial, once-off increase in investment returns 1 Transitioning distribution towards greater reliance on own channels, with a focus on expanding and diversifying the mix of channels 2 Membership count (‘m) - 1.0 2.0 3.0 4.0 Dec-22 Dec-23 Dec-24 Dec-25 Jan-26 Agency Health Plans WSH WSH Health Plan Employers -- 67 of 73 -- 68 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 Ping An Health Insurance PAHI’s operating results pre-tax Discovery’s operating result after tax PAHI licence new business1 PAHI licence earned premium1 +59% +38% +8% to RMB1.4bn (RMB361m DSY’s share) to RMB235m to RMB1.9bn Lives +17% to 34.1m PAHI licence lives 1 100% of PAHI RMB millions RMB millions RMB millions RMB millions +123% before investment income Jun-19 Jun-20 Jun-21 Jun-22 Jun-23 Jun-24 Jun-25 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 H1 2022 H1 2023 H1 2024 H1 2025 H1 2026 27% growth in investment income and gains +15% to RMB9.5bn Investment income and gains Profit before investment income and gains -- 68 of 73 -- 69 Transitioning distribution towards greater reliance on own channels Superior operational performance New business split (%) Growing non-PAL new business Broader growth strategy Focusing on expanding and diversifying the mix of distribution channels YoY change in SuiShenYi new business +60% Positioning SuiShenYi as the primary engine for long-term growth YoY change in online new business +159% Expanding online distribution and capitalising on growth in online channels Net profit margin -4% -2% 0% 2% 4% 6% 8% 10% 12% 14% 2019 2020 2021 2022 2023 2024 2025 H1 2024 H1 2025 H1 2026 Other PAL eShengBao -- 69 of 73 -- 70 Performance overview Normalised profit +24% to R8 891m Headline earnings +29% to R5 692m Normalised headline earnings +27% to R5 745m Dividend +28% to 111 cps New business +12% to R14 026m -- 70 of 73 -- 71 Summary -- 71 of 73 -- 72 Presentation disclaimer This presentation may contain forward looking statements with respect to certain of Discovery’s plans and its current goals and expectations relating to its future performance and results. All forward looking statements involve risk and uncertainty because they relate to future events and circumstances which are beyond Discovery’s control. Accordingly, Discovery’s actual future financial performance and results may differ. Any reference to future financial performance has not been reviewed or reported on by the Group’s auditors. -- 72 of 73 -- Unaudited Interim Results for the six months ended 31 December 2025 -- 73 of 73 --